Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Sanofi Pasteur Poised For Restructuring
by Alex Scott
July 16, 2012
| A version of this story appeared in
Volume 90, Issue 29
Sanofi Pasteur, the France-based vaccines subsidiary of Sanofi, is about to be restructured to improve its profitability. The company is set to introduce measures to enhance the performance of its manufacturing activities and support functions. Sanofi says that it has begun talks with workers’ representatives about the plan but that no specific job cut numbers have been proposed. The French newspaper Le Figaro reports that the restructuring will lead to the loss of 2,000 jobs across France.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter